Molecular Diagnostics
Multidrug-Resistant TB Outbreak Undetected by Standard Tests
Rapid diagnosis of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs is essential to prevent further acquisition of drug resistance, high morbidity and mortality, and unabated transmission of resistant strains. More...31 Oct 2018
Chronic Inflammation Linked to Risk for Alzheimer's Disease
While it has been widely shown that possessing the apolipoprotein E4 (ApoE4) gene is the major genetic risk factor of Alzheimer's disease (AD), not all ApoE4 carriers develop AD. It is likely that a complex interaction of genetic vulnerabilities with environmental risk factors lead to AD and identifying such factors could be beneficial for the prevention of AD. More...30 Oct 2018
Fatal Prostate Cancer Differentiated from Manageable Cancer
Human prostate cancers display numerous DNA methylation changes compared to normal tissue samples. However, definitive identification of features related to the cells’ malignant status has been compromised by the predominance of cells with luminal features in prostate cancers. More...29 Oct 2018
CD MicroRNA Marks Subtypes with Differing Outcomes
Crohn’s disease (CD), one of the primary inflammatory bowel diseases (IBD), is a chronic inflammatory condition of the gastrointestinal tract resulting from an aberrant immune response to the enteric microbiota in a genetically susceptible host. More...25 Oct 2018
Novel Technology Enables Detection of Early-Stage Cancer
Non-small-cell lung carcinoma (NSCLC) is often fatal because most cases are not diagnosed until they are so advanced that surgical intervention is no longer possible. To improve outcomes a blood test has been developed to detect lung cancer earlier in the disease. More...24 Oct 2018
Epigenomic Method Developed to Detect Pancreatic Cancer
Pancreatic cancers are typically diagnosed at late stage where disease prognosis is poor as exemplified by a 5-year survival rate of 8.2%. Earlier diagnosis would be beneficial by enabling surgical resection or earlier application of therapeutic regimens. More...24 Oct 2018
New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Cooling Table Centrifuge
MPW-352R
New
Fixed Volume Pipettor
Labpette FX
In Other News
Multiple Myeloma Subtypes Linked to Patient Ancestry
Test Identifies More Treatable Cancer Mutations Than Biopsies
Rapid Test Detects Drugs of Abuse in Fingerprint Samples
Molecular Diagnostics Prevents Malaria in Blood Banks
Study Shows Zika Virus Persists in Body Fluids
Next-Gen Test Authorized for Minimal Residual Disease
Human Pegivirus Identified in Encephalitis Patients
Novel Fecal Biomarker Found for Colorectal Cancer
Individual HPV Types Linked to HIV Infection
Detection System Used for Monitoring Small Molecules
Antibiotic-Resistant Mutations Revealed by Sequencing Method
Disease-Associated Variants in Genes Allow Early Diagnosis
New Gene Variants Associated with Chronic Back Pain
TB Sequencing Could Replace Drug Susceptibility Testing
Cancer Liquid Biopsy Assay Detects Low-Level Mutations
Pneumonia Diagnosed by Nanopore Sequencing of Sputum
Nanopore Sequencing Enables Outbreak Field Surveillance
Dementia Assay Gets Favorable Evaluation
Disease Progression Apprised by Post-Treatment Mutation Sequencing
DNA Test Predicts Risk of Leukemia Relapse
MALDI-TOF MS Used to Identify Pythiosis
Determining Fibrosis Stage in Non-Alcoholic Fatty Liver Disease
Biomarkers Measured for Early Detection of Huntington's Disease
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
